BIOCATALYSTS LIMITED

1. BIOCATALYSTS LIMITED 1995-10-13 → present
2. BIOCATALYSTS HOLDINGS LIMITED 1991-01-30 → 1995-10-13
3. M.B.H.12 LIMITED 1990-12-24 → 1991-01-30

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

MHA Chartered Accountants and Statutory Auditor

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Group structure

1. BIOCATALYSTS LIMITED · parent
   1. Biocatalysts Inc 100% · USA · Supply of high technology enzymes
   2. Weiss BioTech GmbH 100% · Germany · Production and sale of enzymes
   3. Biosun Biochemicals Inc 100% · USA · Supply of high tech enzymes and ingredients
   4. Weriol Group BV 62% · Netherlands · Holding company
   5. Breatec BV 100% · Netherlands · Production and sale of enzymes

Significant events

• “On 10 April 2025, Biocatalysts Limited exercised their option to purchase the remaining shares in Weriol Group BV meaning 100% of the company is owned within the group. The purchase price was €1,677,137.”
• “On 1 October 2024 the business and assets of Biocatalysts Inc were contributed to Biosun Biochemicals Inc as part of a contribution agreement.”
• “On 3 December 2024, 4,845,563 Ordinary A Shares and 50,197 Ordinary B Shares of Biocatalysts Limited were redesignated as Ordinary Shares.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

2

last 24 months

Officers appointed

1

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +75.5%

  £20,605,182 → £36,168,966

• Cash

  +21.9%

  £2,472,802 → £3,014,597

• Net assets

  +5.8%

  £11,917,617 → £12,610,708

• Employees

  +36.6%

  101 → 138

• Operating profit

  -36.2%

  £3,323,346 → £2,119,151

• Profit before tax

  -66.6%

  £3,033,925 → £1,013,154

• Wages

  +46.6%

  £4,745,278 → £6,955,239

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers